Restrictive Fluid Administration vs. Standard of Care in Emergency Department Sepsis Patients (REFACED Sepsis)-protocol for a multicenter, randomized, clinical, proof-of-concept trial.
Marie Kristine JessenLars Wiuff AndersenMarie-Louise Holm ThomsenPeter KristensenWazhma HayeriRanva Espegård HasselAnders PernerJens Aage Kølsen PetersenHans KirkegaardPublished in: Pilot and feasibility studies (2022)
EudraCT number: 2021-000224-35 (date: 2021 May 03), ClinicalTrials.gov number: NCT05076435 (date: 2021 October 13), Committee on Health Research Ethics - Central Denmark Region: 1-10-72-163-21 (date: 2021 June 28).
Keyphrases
- emergency department
- end stage renal disease
- phase iii
- double blind
- intensive care unit
- acute kidney injury
- healthcare
- newly diagnosed
- septic shock
- phase ii
- randomized controlled trial
- open label
- clinical trial
- prognostic factors
- chronic kidney disease
- study protocol
- peritoneal dialysis
- placebo controlled
- quality improvement
- machine learning
- patient reported outcomes
- pain management
- artificial intelligence
- adverse drug